ACE and heart failure: Embarking on a tailored exploration of heart failure’s mosaic, our subgroup analysis, encapsulated in Table 3, unravels the nuanced interactions between age, disease severity, and the cost-effectiveness profiles of ACE inhibitors and ARBs.